We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Says ‘No’ to Praluent, Endorses Competitor Repatha
NICE Says ‘No’ to Praluent, Endorses Competitor Repatha
The UK’s National Institute for Health and Care Excellence has given a thumbs-down to the cholesterol drug Praluent, but a tentative nod to competitor Repatha.